In this process, we identified pathways enriched within each signature and found that hub genes correspond to lupus susceptibility risk loci (such as the PTPRC, ITGAM, NCF1 and IRF8 genes), reinforcing their pathogenic role in LN and the progression from preclinical to clinical kidney disease. The gene discussed is IRF8; the disease is lobular neoplasia.